PMID- 33017789 OWN - NLM STAT- MEDLINE DCOM- 20210514 LR - 20210514 IS - 1873-3557 (Electronic) IS - 1386-1425 (Linking) VI - 246 DP - 2021 Feb 5 TI - N-substitution in isatin thiosemicarbazones decides nuclearity of Cu(II) complexes - Spectroscopic, molecular docking and cytotoxic studies. PG - 118963 LID - S1386-1425(20)30942-2 [pii] LID - 10.1016/j.saa.2020.118963 [doi] AB - The mono- (1) and bi-nuclear (2) copper(II) complexes containing N-substituted isatin thiosemicarbazone(s) were synthesized, and characterized by analytical and spectroscopic (UV-Visible, FT-IR and EPR) techniques. Bimetallic nature of complex 2 was confirmed by single crystal X-ray crystallography. The structures predicted by spectroscopic and crystallographic methods were validated by computational studies. From the spectroscopic, crystallographic and computational data, the structures were found to be distorted square planar for 1 and distorted square pyramidal for 2. Molecular docking studies showed hydrogen bonding and hydrophobic interactions of the complexes with tyrosinase kinase receptors. Complex 1 exhibited promising cytotoxic activity against Jurkat (leukemia) cell line, and complex 2 displayed more activity against HeLa S3 (cervical) and Jurkat cell lines with the IC(50) values of 3.53 and 3.70 muM, respectively. Cytotoxicity of 1 (Jurkat) and 2 (Jurkat and HeLa S3) was better than that of cisplatin. Morphological changes in A549 (lung), HeLa S3 and Jurkat cell lines were examined in presence of the active complexes with the co-staining of Hoechst, AO (acridine orange) and EB (ethidium bromide) by fluorescence microscope. CI - Copyright (c) 2020 Elsevier B.V. All rights reserved. FAU - Haribabu, Jebiti AU - Haribabu J AD - Department of Chemistry, National Institute of Technology, Tiruchirappalli 620015, India; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Japan. FAU - Alajrawy, Othman I AU - Alajrawy OI AD - College of Applied Science, Department of Applied Chemistry, University of Fallujah, Fallujah 00964, Iraq. FAU - Jeyalakshmi, Kumaramangalam AU - Jeyalakshmi K AD - Department of Chemistry, National Institute of Technology, Tiruchirappalli 620015, India; Department of Chemistry, M. Kumarasamy College of Engineering, Karur 639113, India. FAU - Balachandran, Chandrasekar AU - Balachandran C AD - Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Japan. FAU - Krishnan, Dhanabalan Anantha AU - Krishnan DA AD - Centre of Advanced Study in Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai 600025, India. FAU - Bhuvanesh, Nattamai AU - Bhuvanesh N AD - Department of Chemistry, Texas A & M University, College Station, TX 77842, USA. FAU - Aoki, Shin AU - Aoki S AD - Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Japan; Research Institute for Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Japan. FAU - Natarajan, Karuppannan AU - Natarajan K AD - Department of Chemistry, Sri Ramakrishna Mission Vidyalaya College of Arts and Science, Coimbatore 641 020, India. FAU - Karvembu, Ramasamy AU - Karvembu R AD - Department of Chemistry, National Institute of Technology, Tiruchirappalli 620015, India. Electronic address: kar@nitt.edu. LA - eng PT - Journal Article DEP - 20200918 PL - England TA - Spectrochim Acta A Mol Biomol Spectrosc JT - Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy JID - 9602533 RN - 0 (Antineoplastic Agents) RN - 0 (Coordination Complexes) RN - 0 (Thiosemicarbazones) RN - 789U1901C5 (Copper) RN - 82X95S7M06 (Isatin) SB - IM MH - *Antineoplastic Agents/pharmacology MH - *Coordination Complexes/pharmacology MH - Copper MH - Crystallography, X-Ray MH - *Isatin/pharmacology MH - Molecular Docking Simulation MH - Spectroscopy, Fourier Transform Infrared MH - *Thiosemicarbazones/pharmacology OTO - NOTNLM OT - Cu(II) complexes OT - Cytotoxicity OT - Molecular docking OT - Spectroscopy OT - Theoretical calculations OT - Thiosemicarbazones COIS- Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2020/10/06 06:00 MHDA- 2021/05/15 06:00 CRDT- 2020/10/05 20:10 PHST- 2020/07/22 00:00 [received] PHST- 2020/09/08 00:00 [revised] PHST- 2020/09/14 00:00 [accepted] PHST- 2020/10/06 06:00 [pubmed] PHST- 2021/05/15 06:00 [medline] PHST- 2020/10/05 20:10 [entrez] AID - S1386-1425(20)30942-2 [pii] AID - 10.1016/j.saa.2020.118963 [doi] PST - ppublish SO - Spectrochim Acta A Mol Biomol Spectrosc. 2021 Feb 5;246:118963. doi: 10.1016/j.saa.2020.118963. Epub 2020 Sep 18.